{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:52:05Z","timestamp":1761540725632,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":5977,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1111\/j.1538-7836.2006.02045.x","type":"journal-article","created":{"date-parts":[[2006,7,26]],"date-time":"2006-07-26T07:13:05Z","timestamp":1153897985000},"page":"1701-1706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The differential association of conjugated equine estrogen and esterified estrogen with activated protein C resistance in postmenopausal women"],"prefix":"10.1016","volume":"4","author":[{"given":"N.L.","family":"SMITH","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.R.","family":"HECKBERT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.J.","family":"DOGGEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.N.","family":"LEMAITRE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.P.","family":"REINER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"LUMLEY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.M.","family":"MEIJERS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.M.","family":"PSATY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.R.","family":"ROSENDAAL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2006.02045.x_bb0010","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/progestin Replacement Study (HERS) Research Group","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"10.1111\/j.1538-7836.2006.02045.x_bb0015","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1111\/j.1538-7836.2006.02045.x_bb0020","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"key":"10.1111\/j.1538-7836.2006.02045.x_bb0025","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1001\/jama.292.13.1581","article-title":"Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis","volume":"292","author":"Smith","year":"2004","journal-title":"JAMA"},{"key":"10.1111\/j.1538-7836.2006.02045.x_bb0030","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1365-2141.1999.01302.x","article-title":"Acquired APC resistance and oral contraceptives: differences between two functional tests","volume":"105","author":"Curvers","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2006.02045.x_bb0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1365-2141.1997.192707.x","article-title":"Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives","volume":"97","author":"Rosing","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2006.02045.x_bb0040","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0140-6736(99)06092-4","article-title":"Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study","volume":"354","author":"Rosing","year":"1999","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2006.02045.x_bb0045","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1365-2141.2003.04443.x","article-title":"Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women","volume":"122","author":"Tans","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2006.02045.x_bb0050","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1111\/j.1538-7836.2004.00983.x","article-title":"Prothrombotic changes in users of combined oral contraceptives containing drospirenone and cyproterone acetate","volume":"2","author":"Van Vliet","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02045.x_bb0055","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/j.1538-7836.2005.01430.x","article-title":"Determinants of the APTT- and ETP-based APC sensitivity tests","volume":"3","author":"De Visser","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02045.x_bb0060","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/01.ATV.0000074146.36646.C8","article-title":"Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal women","volume":"23","author":"Post","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2006.02045.x_bb0065","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/01.ATV.0000087141.05044.1F","article-title":"Differential effects of oral and transdermal estrogen\/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial","volume":"23","author":"Oger","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2006.02045.x_bb0070","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-0037-1613960","article-title":"A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways","volume":"84","author":"Tans","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02045.x_bb0075","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/archinte.1997.00440330066007","article-title":"Duration of estrogen replacement therapy in relation to the risk of incident myocardial infarction in postmenopausal women","volume":"157","author":"Heckbert","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1538-7836.2006.02045.x_bb0080","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0895-7061(97)00494-9","article-title":"Replacing short-acting nifedipine with alternative medications at a large health maintenance organization","volume":"11","author":"Kaplan","year":"1998","journal-title":"Am J Hypertens"},{"key":"10.1111\/j.1538-7836.2006.02045.x_bb0085","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/00005650-200009000-00010","article-title":"Evaluation of a formulary switch from conjugated to esterified estrogens in a managed care setting","volume":"38","author":"Andrade","year":"2000","journal-title":"Med Care"},{"key":"10.1111\/j.1538-7836.2006.02045.x_bb0090","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1089\/jwh.1998.7.1027","article-title":"Acceptability of a substitution of estrogen replacement therapy to women enrolled in a health maintenance organization","volume":"7","author":"Gardner","year":"1998","journal-title":"J Womens Health"},{"key":"10.1111\/j.1538-7836.2006.02045.x_bb0095","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00001721-199701000-00006","article-title":"Effect of activated protein C on thrombin generation and on the thrombin potential in plasma of normal and APC-resistant individuals","volume":"8","author":"Nicolaes","year":"1997","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1538-7836.2006.02045.x_bb0100","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","article-title":"Mutation in blood coagulation factor V associated with resistance to activated protein C","volume":"369","author":"Bertina","year":"1994","journal-title":"Nature"},{"key":"10.1111\/j.1538-7836.2006.02045.x_bb0105","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1067\/mob.2001.109656","article-title":"The pharmacokinetics and efficacy of different estrogens are not equivalent","volume":"184","author":"Ansbacher","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2006.02045.x_bb0110","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3181\/00379727-217-44199","article-title":"Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: chemistry and metabolism","volume":"217","author":"Bhavnani","year":"1998","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1111\/j.1538-7836.2006.02045.x_bb0115","doi-asserted-by":"crossref","first-page":"18S","DOI":"10.1002\/j.1552-4604.1995.tb04143.x","article-title":"Pharmacokinetic and pharmacologic variation between different estrogen products","volume":"35","author":"O'Connell","year":"1995","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/j.1538-7836.2006.02045.x_bb0120","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1055\/s-0038-1646283","article-title":"Coagulation activation following estrogen administration to postmenopausal women","volume":"68","author":"Caine","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02045.x_bb0125","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1471-0528.2003.02165.x","article-title":"Hormone replacement therapy and hypercoagulability. Results from the Prospective Collaborative Danish Climacteric Study","volume":"110","author":"Sidelmann","year":"2003","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1111\/j.1538-7836.2006.02045.x_bb0130","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1161\/01.ATV.17.11.3071","article-title":"Effects of oral and transdermal estrogen\/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial","volume":"17","author":"Scarabin","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2006.02045.x_bb0135","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1046\/j.1365-2141.2002.03957.x","article-title":"Increased resistance to activated protein C after short-term oral hormone replacement therapy in healthy post-menopausal women","volume":"119","author":"Post","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2006.02045.x_bb0140","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1067\/S0002-9378(03)00599-4","article-title":"Effects of low-dose oral and transdermal estrogen replacement therapy on hemostatic factors in healthy postmenopausal women: a randomized placebo-controlled study","volume":"189","author":"Post","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2006.02045.x_bb0145","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1046\/j.1365-2141.2001.02911.x","article-title":"Post-menopausal hormone therapy and concentrations of protein C and antithrombin in elderly women","volume":"114","author":"Cushman","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2006.02045.x_bb0150","first-page":"237","article-title":"Hormone replacement therapy in healthy postmenopausal women: a randomized, placebo-controlled study of effects on coagulation and fibrinolytic factors","volume":"249","author":"Gottsater","year":"2001","journal-title":"J Intern Med"},{"key":"10.1111\/j.1538-7836.2006.02045.x_bb0155","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00001721-200412000-00004","article-title":"Effect of raloxifene on activated protein C (APC) resistance in postmenopausal women and on APC resistance and homocysteine levels in elderly men: two randomized placebo-controlled studies","volume":"15","author":"Duschek","year":"2004","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1538-7836.2006.02045.x_bb0160","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1365-2141.2001.03111.x","article-title":"Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial","volume":"115","author":"Hoibraaten","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2006.02045.x_bb0165","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1538-7836.2005.01335.x","article-title":"Decreased plasma sensitivity to activated protein C by oral contraceptives is associated with decreases in plasma glucosylceramide","volume":"3","author":"Deguchi","year":"2005","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2006.02045.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622175458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622175458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2006.02045.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:38:32Z","timestamp":1761532712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622175458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S1538783622175458"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2006.02045.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"type":"print","value":"1538-7836"}],"subject":[],"published":{"date-parts":[[2006,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The differential association of conjugated equine estrogen and esterified estrogen with activated protein C resistance in postmenopausal women","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2006.02045.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}